Cargando…
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation
BACKGROUND: Breast cancer (BC) is the most common malignancy affecting women. It is vital to explore sensitive biological markers to diagnose and treat BC patients. Recent studies have proved that long noncoding RNAs (lncRNAs) were involved in breast tumor progression. Nonetheless, whether lncRNA pr...
Autores principales: | Feng, Jianyuan, Zhang, Jiarui, Li, Yanling, Cheng, Weilun, Liu, Yansong, Chen, Ziang, Duan, Yunqiang, Yu, Tianshui, Hu, Anbang, Wang, Ting, Zhang, Hanyu, Li, Mingcui, Rong, Zhiyuan, Ma, Fei, Guo, Baoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242319/ https://www.ncbi.nlm.nih.gov/pubmed/36992525 http://dx.doi.org/10.1002/cam4.5872 |
Ejemplares similares
-
LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis
por: Ding, Yu, et al.
Publicado: (2022) -
Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
por: Li, Yanling, et al.
Publicado: (2022) -
Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study
por: Yu, Tianshui, et al.
Publicado: (2022) -
BPIFB1 promotes metastasis of hormone receptor‐positive breast cancer via inducing macrophage M2‐like polarization
por: Hu, Anbang, et al.
Publicado: (2023) -
The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021)